Extracellular Adenosine Triphosphate and Chronic Obstructive Pulmonary Disease
Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown. To analyze the expression of ATP and its functional consequences in never-smokers, asymptomatic smokers, and patients with COPD. ATP was quantified in bronchoalveolar lavage fluid (BALF)...
Saved in:
Published in | American journal of respiratory and critical care medicine Vol. 181; no. 9; pp. 928 - 934 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
American Thoracic Society
01.05.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown.
To analyze the expression of ATP and its functional consequences in never-smokers, asymptomatic smokers, and patients with COPD.
ATP was quantified in bronchoalveolar lavage fluid (BALF) of never-smokers, asymptomatic smokers, and patients with COPD of different severity. The expression of specific ATP (purinergic) receptors was measured in airway macrophages and blood neutrophils from control subjects and patients with COPD. The release of mediators by macrophages and neutrophils and neutrophil chemotaxis was assessed after ATP stimulation.
Chronic smokers had elevated ATP concentrations in BALF compared with never-smokers. Acute smoke exposure led to a further increase in endobronchial ATP concentrations. Highest ATP concentrations in BALF were present in smokers and ex-smokers with COPD. In patients with COPD, BALF ATP concentrations correlated negatively with lung function and positively with BALF neutrophil counts. ATP induced a stronger chemotaxis and a stronger elastase release in blood neutrophils from patients with COPD, as compared with control subjects. In addition, airway macrophages from patients with COPD responded with an increased secretion of proinflammatory and tissue-degrading mediators after ATP stimulation. These findings were accompanied by an up-regulation of specific purinergic receptors in blood neutrophils and airway macrophages of patients with COPD.
COPD is characterized by a strong and persistent up-regulation of extracellular ATP in the airways. Extracellular ATP appears to contribute to the pathogenesis of COPD by promoting inflammation and tissue degradation. |
---|---|
AbstractList | Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown.RATIONALEExtracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown.To analyze the expression of ATP and its functional consequences in never-smokers, asymptomatic smokers, and patients with COPD.OBJECTIVESTo analyze the expression of ATP and its functional consequences in never-smokers, asymptomatic smokers, and patients with COPD.ATP was quantified in bronchoalveolar lavage fluid (BALF) of never-smokers, asymptomatic smokers, and patients with COPD of different severity. The expression of specific ATP (purinergic) receptors was measured in airway macrophages and blood neutrophils from control subjects and patients with COPD. The release of mediators by macrophages and neutrophils and neutrophil chemotaxis was assessed after ATP stimulation.METHODSATP was quantified in bronchoalveolar lavage fluid (BALF) of never-smokers, asymptomatic smokers, and patients with COPD of different severity. The expression of specific ATP (purinergic) receptors was measured in airway macrophages and blood neutrophils from control subjects and patients with COPD. The release of mediators by macrophages and neutrophils and neutrophil chemotaxis was assessed after ATP stimulation.Chronic smokers had elevated ATP concentrations in BALF compared with never-smokers. Acute smoke exposure led to a further increase in endobronchial ATP concentrations. Highest ATP concentrations in BALF were present in smokers and ex-smokers with COPD. In patients with COPD, BALF ATP concentrations correlated negatively with lung function and positively with BALF neutrophil counts. ATP induced a stronger chemotaxis and a stronger elastase release in blood neutrophils from patients with COPD, as compared with control subjects. In addition, airway macrophages from patients with COPD responded with an increased secretion of proinflammatory and tissue-degrading mediators after ATP stimulation. These findings were accompanied by an up-regulation of specific purinergic receptors in blood neutrophils and airway macrophages of patients with COPD.MEASUREMENTS AND MAIN RESULTSChronic smokers had elevated ATP concentrations in BALF compared with never-smokers. Acute smoke exposure led to a further increase in endobronchial ATP concentrations. Highest ATP concentrations in BALF were present in smokers and ex-smokers with COPD. In patients with COPD, BALF ATP concentrations correlated negatively with lung function and positively with BALF neutrophil counts. ATP induced a stronger chemotaxis and a stronger elastase release in blood neutrophils from patients with COPD, as compared with control subjects. In addition, airway macrophages from patients with COPD responded with an increased secretion of proinflammatory and tissue-degrading mediators after ATP stimulation. These findings were accompanied by an up-regulation of specific purinergic receptors in blood neutrophils and airway macrophages of patients with COPD.COPD is characterized by a strong and persistent up-regulation of extracellular ATP in the airways. Extracellular ATP appears to contribute to the pathogenesis of COPD by promoting inflammation and tissue degradation.CONCLUSIONSCOPD is characterized by a strong and persistent up-regulation of extracellular ATP in the airways. Extracellular ATP appears to contribute to the pathogenesis of COPD by promoting inflammation and tissue degradation. Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown. To analyze the expression of ATP and its functional consequences in never-smokers, asymptomatic smokers, and patients with COPD. ATP was quantified in bronchoalveolar lavage fluid (BALF) of never-smokers, asymptomatic smokers, and patients with COPD of different severity. The expression of specific ATP (purinergic) receptors was measured in airway macrophages and blood neutrophils from control subjects and patients with COPD. The release of mediators by macrophages and neutrophils and neutrophil chemotaxis was assessed after ATP stimulation. Chronic smokers had elevated ATP concentrations in BALF compared with never-smokers. Acute smoke exposure led to a further increase in endobronchial ATP concentrations. Highest ATP concentrations in BALF were present in smokers and ex-smokers with COPD. In patients with COPD, BALF ATP concentrations correlated negatively with lung function and positively with BALF neutrophil counts. ATP induced a stronger chemotaxis and a stronger elastase release in blood neutrophils from patients with COPD, as compared with control subjects. In addition, airway macrophages from patients with COPD responded with an increased secretion of proinflammatory and tissue-degrading mediators after ATP stimulation. These findings were accompanied by an up-regulation of specific purinergic receptors in blood neutrophils and airway macrophages of patients with COPD. COPD is characterized by a strong and persistent up-regulation of extracellular ATP in the airways. Extracellular ATP appears to contribute to the pathogenesis of COPD by promoting inflammation and tissue degradation. Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown. To analyze the expression of ATP and its functional consequences in never-smokers, asymptomatic smokers, and patients with COPD. ATP was quantified in bronchoalveolar lavage fluid (BALF) of never-smokers, asymptomatic smokers, and patients with COPD of different severity. The expression of specific ATP (purinergic) receptors was measured in airway macrophages and blood neutrophils from control subjects and patients with COPD. The release of mediators by macrophages and neutrophils and neutrophil chemotaxis was assessed after ATP stimulation. Chronic smokers had elevated ATP concentrations in BALF compared with never-smokers. Acute smoke exposure led to a further increase in endobronchial ATP concentrations. Highest ATP concentrations in BALF were present in smokers and ex-smokers with COPD. In patients with COPD, BALF ATP concentrations correlated negatively with lung function and positively with BALF neutrophil counts. ATP induced a stronger chemotaxis and a stronger elastase release in blood neutrophils from patients with COPD, as compared with control subjects. In addition, airway macrophages from patients with COPD responded with an increased secretion of proinflammatory and tissue-degrading mediators after ATP stimulation. These findings were accompanied by an up-regulation of specific purinergic receptors in blood neutrophils and airway macrophages of patients with COPD. COPD is characterized by a strong and persistent up-regulation of extracellular ATP in the airways. Extracellular ATP appears to contribute to the pathogenesis of COPD by promoting inflammation and tissue degradation. |
Author | Idzko, Marco Di Virgilio, Francesco Lungarella, Giuseppe Müller, Tobias Zissel, Gernot Ferrari, Davide Lommatzsch, Marek Lucattelli, Monica Bratke, Kai Dürk, Thorsten Virchow, J. Christian Grimm, Melanie Sorichter, Stephan Cicko, Sanja Stoll, Paul |
Author_xml | – sequence: 1 givenname: Marek surname: Lommatzsch fullname: Lommatzsch, Marek – sequence: 2 givenname: Sanja surname: Cicko fullname: Cicko, Sanja – sequence: 3 givenname: Tobias surname: Müller fullname: Müller, Tobias – sequence: 4 givenname: Monica surname: Lucattelli fullname: Lucattelli, Monica – sequence: 5 givenname: Kai surname: Bratke fullname: Bratke, Kai – sequence: 6 givenname: Paul surname: Stoll fullname: Stoll, Paul – sequence: 7 givenname: Melanie surname: Grimm fullname: Grimm, Melanie – sequence: 8 givenname: Thorsten surname: Dürk fullname: Dürk, Thorsten – sequence: 9 givenname: Gernot surname: Zissel fullname: Zissel, Gernot – sequence: 10 givenname: Davide surname: Ferrari fullname: Ferrari, Davide – sequence: 11 givenname: Francesco surname: Di Virgilio fullname: Di Virgilio, Francesco – sequence: 12 givenname: Stephan surname: Sorichter fullname: Sorichter, Stephan – sequence: 13 givenname: Giuseppe surname: Lungarella fullname: Lungarella, Giuseppe – sequence: 14 givenname: J. Christian surname: Virchow fullname: Virchow, J. Christian – sequence: 15 givenname: Marco surname: Idzko fullname: Idzko, Marco |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22702315$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20093639$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1r3DAQxUVIyce2_0AOwQRKT05HkmVbx7DdfkDo9pBCb2I8K7MKtrSR7ND-99WyGwo59DRz-L3HzHuX7NQHbxm74nDLeV19jETjrQDQHEquoF4vT9gFV1KVlW7gNO_QyLKq9K9zdpnSIwAXLYczdr4XyVrqC_Z99XuKSHYY5gFjcbexPiTnbfEQ3W4b0m6Lky3Qb4rlNgbvqFh3aYozTe7ZFj_mYQwe45_ik0sWk33L3vQ4JPvuOBfs5-fVw_Jreb_-8m15d1-SVHoq667jqkJorQABlgsSPbXQ9qSBCBuUgFJQwzteI9c9kW4RBVeql0pWlVywDwffXQxPs02TGV3af4HehjmZRkrFtRRNJm9ekY9hjj4fZ7jWNWit6gxdH6G5G-3G7KIb81fmJacMvD8CmAiHPqInl_5xogEhc_QL1h44iiGlaHtDbsLJBZ9TdoPhYPbVmX115lCdOVSXpeKV9MX9P6K_SoScEA |
CitedBy_id | crossref_primary_10_1152_ajplung_00061_2019 crossref_primary_10_3109_19401736_2015_1126826 crossref_primary_10_1007_s00408_023_00659_x crossref_primary_10_1016_j_jaci_2012_05_040 crossref_primary_10_1111_apm_13089 crossref_primary_10_1016_j_ajpath_2016_03_002 crossref_primary_10_3389_fphys_2014_00096 crossref_primary_10_1165_rcmb_2012_0493OC crossref_primary_10_1152_ajplung_00174_2015 crossref_primary_10_1085_jgp_201711870 crossref_primary_10_1136_thoraxjnl_2014_205467 crossref_primary_10_1165_rcmb_2011_0267OC crossref_primary_10_2478_jtim_2022_0019 crossref_primary_10_1007_s11302_022_09877_z crossref_primary_10_1152_ajplung_00344_2012 crossref_primary_10_1164_rccm_201108_1574OC crossref_primary_10_1152_ajplung_00329_2019 crossref_primary_10_1038_s41598_019_39233_y crossref_primary_10_1007_s11302_022_09895_x crossref_primary_10_1016_j_autneu_2021_102859 crossref_primary_10_2174_2666121702666220429095250 crossref_primary_10_1007_s13738_017_1138_5 crossref_primary_10_3389_fimmu_2020_01205 crossref_primary_10_1016_j_cryobiol_2023_104569 crossref_primary_10_1124_pr_117_014878 crossref_primary_10_1371_journal_pone_0024097 crossref_primary_10_5482_HAMO_14_09_0044 crossref_primary_10_1021_bi401621d crossref_primary_10_1007_s00424_018_2160_x crossref_primary_10_1016_j_pupt_2015_01_005 crossref_primary_10_1183_23120541_00002_2016 crossref_primary_10_3389_fimmu_2017_01028 crossref_primary_10_1016_j_micinf_2011_03_004 crossref_primary_10_3390_ph14100979 crossref_primary_10_1186_s12931_015_0264_9 crossref_primary_10_3389_fimmu_2023_1310098 crossref_primary_10_1111_bph_13518 crossref_primary_10_1182_blood_2010_10_313957 crossref_primary_10_1186_s12967_015_0645_3 crossref_primary_10_1038_mi_2013_77 crossref_primary_10_3389_fphys_2021_720538 crossref_primary_10_1183_13993003_02144_2014 crossref_primary_10_3389_fimmu_2018_00832 crossref_primary_10_1186_s12967_024_05100_2 crossref_primary_10_1007_s00441_016_2567_7 crossref_primary_10_1016_j_jaci_2015_10_044 crossref_primary_10_1152_ajplung_00225_2012 crossref_primary_10_1164_rccm_201102_0280UP crossref_primary_10_1016_j_arcmed_2020_12_010 crossref_primary_10_1155_2013_413735 crossref_primary_10_1165_rcmb_2010_0038OC crossref_primary_10_1016_S0140_6736_11_60988_4 crossref_primary_10_1183_16000617_0040_2017 crossref_primary_10_18632_oncotarget_7518 crossref_primary_10_1111_j_1398_9995_2011_02586_x crossref_primary_10_17116_terarkh201587398_104 crossref_primary_10_1378_chest_12_0930 crossref_primary_10_1016_j_cyto_2020_155220 crossref_primary_10_1002_wmts_69 crossref_primary_10_1007_s12026_011_8203_4 crossref_primary_10_1371_journal_pone_0101855 crossref_primary_10_1186_s12931_016_0438_0 crossref_primary_10_1038_nature13085 crossref_primary_10_2147_COPD_S246219 crossref_primary_10_1016_j_cej_2024_152332 crossref_primary_10_1002_jnr_22817 crossref_primary_10_1152_ajplung_00351_2011 crossref_primary_10_1016_j_vetimm_2012_06_011 crossref_primary_10_1113_JP274731 crossref_primary_10_1183_13993003_01571_2017 crossref_primary_10_1513_AnnalsATS_201503_126AW crossref_primary_10_3389_fphys_2021_614330 crossref_primary_10_1165_rcmb_2014_0008OC crossref_primary_10_1111_j_1476_5381_2012_01892_x crossref_primary_10_3390_biomedicines9060656 crossref_primary_10_1038_s41598_019_51855_w crossref_primary_10_1089_hum_2023_078 crossref_primary_10_3389_fimmu_2014_00656 crossref_primary_10_3389_fimmu_2022_866097 crossref_primary_10_1155_2018_6798238 crossref_primary_10_1165_rcmb_2010_0129OC crossref_primary_10_18632_oncotarget_25761 crossref_primary_10_1080_07853890_2019_1639809 crossref_primary_10_1183_13993003_01357_2016 crossref_primary_10_1038_nrd4025 crossref_primary_10_1186_s12931_018_0793_0 crossref_primary_10_18632_oncotarget_16414 crossref_primary_10_1089_ars_2015_6407 crossref_primary_10_3389_fimmu_2016_00439 crossref_primary_10_1016_S0140_6736_14_61740_2 crossref_primary_10_1016_j_pharmthera_2011_03_007 crossref_primary_10_1111_resp_12542 crossref_primary_10_1007_s00408_020_00377_8 crossref_primary_10_1093_toxsci_kfr044 crossref_primary_10_3390_ijms25094652 crossref_primary_10_1146_annurev_physiol_061121_035838 crossref_primary_10_1096_fj_15_274563 crossref_primary_10_2217_pmt_12_16 crossref_primary_10_1016_j_acmx_2013_01_010 crossref_primary_10_3389_fimmu_2019_01633 crossref_primary_10_1164_rccm_201003_0359OC crossref_primary_10_1016_j_biocel_2016_07_026 crossref_primary_10_1124_mol_112_083493 crossref_primary_10_3390_geosciences4030128 crossref_primary_10_1371_journal_pone_0101087 crossref_primary_10_1152_physrev_00039_2015 crossref_primary_10_1007_s00109_011_0767_x crossref_primary_10_1111_febs_16563 crossref_primary_10_1016_j_bcp_2020_114319 crossref_primary_10_1378_chest_10_2471 crossref_primary_10_1164_rccm_201412_2230OC crossref_primary_10_3390_metabo11030161 crossref_primary_10_1016_j_chest_2016_06_045 crossref_primary_10_1155_2018_1309746 crossref_primary_10_1007_s11882_017_0695_0 crossref_primary_10_1152_ajplung_00450_2020 crossref_primary_10_1007_s40136_019_00239_9 crossref_primary_10_1378_chest_13_1885 crossref_primary_10_1146_annurev_physiol_021113_170411 crossref_primary_10_1016_j_compbiomed_2020_103703 crossref_primary_10_1016_j_ejphar_2010_04_019 crossref_primary_10_1159_000441299 crossref_primary_10_1172_JCI81113 crossref_primary_10_4049_jimmunol_1501585 crossref_primary_10_1124_pr_111_005389 crossref_primary_10_1186_s12931_022_02072_z crossref_primary_10_1007_s11302_011_9271_6 crossref_primary_10_1183_13993003_02322_2016 crossref_primary_10_1016_j_lungcan_2015_10_005 crossref_primary_10_1016_j_alit_2017_06_010 crossref_primary_10_1089_jamp_2013_1089 crossref_primary_10_1007_s00281_016_0559_z crossref_primary_10_1080_15412555_2020_1783648 crossref_primary_10_1016_j_chest_2017_03_020 crossref_primary_10_1016_j_coph_2023_102404 crossref_primary_10_1007_s12026_024_09497_2 crossref_primary_10_1186_s12931_024_02807_0 crossref_primary_10_1002_ctm2_1343 crossref_primary_10_1152_ajplung_00229_2013 crossref_primary_10_1111_apm_13095 crossref_primary_10_1586_1744666X_2013_828875 crossref_primary_10_1016_j_ejphar_2010_09_041 crossref_primary_10_1371_journal_pone_0112829 crossref_primary_10_1124_jpet_112_198051 crossref_primary_10_4155_fmc_13_6 crossref_primary_10_3892_mmr_2015_4622 crossref_primary_10_1038_nri3739 crossref_primary_10_1164_rccm_202106_1426OC crossref_primary_10_1371_journal_pone_0204229 |
Cites_doi | 10.1056/NEJMe0910626 10.1056/NEJMra0804752 10.1016/j.imbio.2008.12.001 10.1183/09031936.00089807 10.1097/00004872-200307000-00024 10.1182/blood-2005-07-2994 10.1074/jbc.271.26.15597 10.1097/SHK.0b013e318160dad4 10.1183/09031936.00036307 10.1084/jem.185.1.153 10.4049/jimmunol.181.3.2181 10.1038/sj.bjp.0705145 10.1183/09031936.00090109 10.1016/j.pharmthera.2005.04.013 10.1124/pr.58.1.5 10.1038/nm1617 10.1136/thx.2005.049502 10.1126/science.1132559 10.1189/jlb.1206758 10.1056/NEJMoa0904006 10.4049/jimmunol.166.11.6754 10.1097/01.mcp.0000199002.46038.cb 10.1056/NEJMra071714 10.1371/journal.pone.0002599 10.4049/jimmunol.176.7.3877 10.1056/NEJMoa032158 10.1007/s00011-008-8009-6 10.1073/pnas.0400733101 10.1165/rcmb.2007-0400OC 10.1164/rccm.200703-456SO 10.1182/blood.V100.3.925 10.1136/thx.2004.024463 10.1016/j.pupt.2007.12.003 10.1016/j.tips.2009.07.005 10.1152/ajpcell.00287.2003 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Copyright American Thoracic Society May 1, 2010 |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright American Thoracic Society May 1, 2010 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1164/rccm.200910-1506OC |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Academic Middle East (New) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-4970 |
EndPage | 934 |
ExternalDocumentID | 2027524921 20093639 22702315 10_1164_rccm_200910_1506OC |
Genre | Journal Article Comparative Study |
GroupedDBID | --- -~X .55 .GJ 0R~ 23M 2WC 34G 39C 3O- 53G 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8FW 8R4 8R5 AAWTL AAYXX ABJNI ABOCM ABPMR ABUWG ACGFO ACGFS ADBBV AENEX AFCHL AFFNX AFKRA AHMBA AI. ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CITATION CS3 DIK E3Z EBS EJD EMOBN EX3 F5P FRP FYUFA GX1 HMCUK HZ~ IH2 J5H KQ8 L7B M1P M5~ NAPCQ O9- OBH OFXIZ OGEVE OHT OK1 OVD OVIDX P2P PCD PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RWL SJN TAE TEORI THO TR2 UKHRP VH1 W8F WH7 WOQ WOW X7M ZE2 ZGI ZXP ~02 1CY 1KJ AAEJM AAQQT ACBNA AFUWQ AJJEV H13 IQODW N4W PJZUB PPXIY YJK CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c359t-6bb154a08e2020e12c2fc808fc90cca7a30a32c71b16a19fcc98aa2155f353443 |
IEDL.DBID | 7X7 |
ISSN | 1073-449X 1535-4970 |
IngestDate | Fri Jul 11 08:43:45 EDT 2025 Fri Jul 25 02:39:00 EDT 2025 Mon Jul 21 05:59:11 EDT 2025 Mon Jul 21 09:17:11 EDT 2025 Thu Apr 24 23:12:21 EDT 2025 Tue Jul 01 00:53:35 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Lung disease purinergic receptors Purine nucleoside Adenosine Intensive care Respiratory disease Tobacco smoking smoking Bronchus disease Chronic obstructive pulmonary disease ATP Resuscitation extracellular ATP |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c359t-6bb154a08e2020e12c2fc808fc90cca7a30a32c71b16a19fcc98aa2155f353443 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 |
PMID | 20093639 |
PQID | 199609956 |
PQPubID | 40575 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_733519327 proquest_journals_199609956 pubmed_primary_20093639 pascalfrancis_primary_22702315 crossref_citationtrail_10_1164_rccm_200910_1506OC crossref_primary_10_1164_rccm_200910_1506OC |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-05-01 |
PublicationDateYYYYMMDD | 2010-05-01 |
PublicationDate_xml | – month: 05 year: 2010 text: 2010-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
PublicationTitle | American journal of respiratory and critical care medicine |
PublicationTitleAlternate | Am J Respir Crit Care Med |
PublicationYear | 2010 |
Publisher | American Thoracic Society |
Publisher_xml | – name: American Thoracic Society |
References | BIB16 BIB17 BIB18 BIB19 BIB23 BIB24 BIB25 BIB26 BIB20 BIB21 BIB22 BIB9 BIB8 BIB7 BIB6 BIB27 BIB5 BIB28 BIB4 BIB29 BIB3 BIB2 BIB1 BIB12 BIB34 BIB13 BIB35 BIB14 BIB15 BIB30 BIB31 BIB10 BIB32 BIB11 BIB33 |
References_xml | – ident: BIB29 doi: 10.1056/NEJMe0910626 – ident: BIB4 doi: 10.1056/NEJMra0804752 – ident: BIB28 doi: 10.1016/j.imbio.2008.12.001 – ident: BIB33 doi: 10.1183/09031936.00089807 – ident: BIB27 doi: 10.1097/00004872-200307000-00024 – ident: BIB25 doi: 10.1182/blood-2005-07-2994 – ident: BIB24 doi: 10.1074/jbc.271.26.15597 – ident: BIB13 doi: 10.1097/SHK.0b013e318160dad4 – ident: BIB22 doi: 10.1183/09031936.00036307 – ident: BIB10 doi: 10.1084/jem.185.1.153 – ident: BIB14 doi: 10.4049/jimmunol.181.3.2181 – ident: BIB18 doi: 10.1038/sj.bjp.0705145 – ident: BIB21 doi: 10.1183/09031936.00090109 – ident: BIB8 doi: 10.1016/j.pharmthera.2005.04.013 – ident: BIB9 doi: 10.1124/pr.58.1.5 – ident: BIB19 doi: 10.1038/nm1617 – ident: BIB3 doi: 10.1136/thx.2005.049502 – ident: BIB12 doi: 10.1126/science.1132559 – ident: BIB32 doi: 10.1189/jlb.1206758 – ident: BIB30 doi: 10.1056/NEJMoa0904006 – ident: BIB35 doi: 10.4049/jimmunol.166.11.6754 – ident: BIB6 doi: 10.1097/01.mcp.0000199002.46038.cb – ident: BIB23 doi: 10.1056/NEJMra071714 – ident: BIB26 doi: 10.1371/journal.pone.0002599 – ident: BIB16 doi: 10.4049/jimmunol.176.7.3877 – ident: BIB1 doi: 10.1056/NEJMoa032158 – ident: BIB31 doi: 10.1007/s00011-008-8009-6 – ident: BIB15 doi: 10.1073/pnas.0400733101 – ident: BIB20 doi: 10.1165/rcmb.2007-0400OC – ident: BIB2 doi: 10.1164/rccm.200703-456SO – ident: BIB17 doi: 10.1182/blood.V100.3.925 – ident: BIB5 doi: 10.1136/thx.2004.024463 – ident: BIB11 doi: 10.1016/j.pupt.2007.12.003 – ident: BIB7 doi: 10.1016/j.tips.2009.07.005 – ident: BIB34 doi: 10.1152/ajpcell.00287.2003 |
SSID | ssj0012810 |
Score | 2.404679 |
Snippet | Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown.
To analyze the expression of ATP and its... Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown. To analyze the expression of ATP and its... Extracellular ATP promotes inflammation, but its role in chronic obstructive pulmonary disease (COPD) is unknown.RATIONALEExtracellular ATP promotes... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 928 |
SubjectTerms | Adenosine Triphosphate - analysis Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bronchoalveolar Lavage Fluid - chemistry Chronic obstructive pulmonary disease, asthma Cytokines - analysis Extracellular Fluid - chemistry Female Humans Intensive care medicine Macrophages, Alveolar - chemistry Male Medical sciences Middle Aged Neutrophils - chemistry Pneumology Pulmonary Disease, Chronic Obstructive - metabolism Receptors, Purinergic - analysis Sarcoidosis - metabolism Smoking - metabolism Up-Regulation |
Title | Extracellular Adenosine Triphosphate and Chronic Obstructive Pulmonary Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20093639 https://www.proquest.com/docview/199609956 https://www.proquest.com/docview/733519327 |
Volume | 181 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aBEohlD5TN-2iQ29FxLIetk8l3W4IhWxCSWBvRpYlcgje7XoT2n_fGVt2yaG5-KIHeD49vtG8AD5nZchE8Jbr3DmukMFya8qaW1xMjdQ2F4EUxfOlObtWP1Z6FX1zuuhWOZ6J_UHdrB29kR-Tt2xKYZhfN784FY0i42qsoPEU9ilzGXl05atJ3yIb0ZCMIJdcqXI1xswYdbx1rg9DL8k3QafmYv7gXjrY2A5FFIbaFv8nn_0ldPoSXkT2yE4GuF_BE9--hmfn0T7-BpaL37utpcd48i5lJw2lAscWdoVnw82629wgtWS2bVhMissu6phB9t6zy7tb_E27_cO-D2abt3B9urian_FYMYE7qcsdN3WNlMimhc-QBnqRuSy4Ii2CK1OEKkcErMxcLmphrCiDc2VhLd76OkgtlZLvYK9dt_49MI_Ux9QyIKVwSjUWO6NyVBsrvdBe2wTEKK_KxXTiVNXiturVCqMqknE1yLgaZJzAl2nMZkim8Wjv2QMYpiEZxdBJoRM4GnGp4s7rqmmdJMCmVtwyJHrb-vVdV-VS9rw1T-BwQPPf1PTCg6Ttw6NTH8Hz0YkgFR9hD3Hyn5Cb7OpZvwLxW8zFDPa_LZaXP_8CwHTj9A |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB7RRWorVVXfTaHUh_ZURcTxI8mhQhQWLYVdULVIewuOY4sDym43S1t-VP8j48QJ4lBunG2Pkpmx_Y3nBfA5zmxMrVGhSLQOOSLYUMmsCBUqU8mESqh1huJ4Ikdn_MdMzNbgX5cL48IquzOxOajLuXZv5NsuWjZyaZg7i1-haxrlnKtdB41WK47M9R-02Opvh_so3i9xfDCc7o1C31Qg1Exkq1AWBaIGFaUGzf7I0FjHVqdRanUW4d8k-JGKxTqhBZWKZlbrLFUKL0ZhmWCcM6T7CNY5Q0tmAOvfh5PTn73bIk59-YOEhZxnsy5LR_LtpdZN4nvmoiFEJE_27tyEzxaqRqHYtpvG_-Fuc-0dvIDnHq-S3VbBXsKaqV7B47H3yL-GyfDvaqnc87-LZyW7pSs-jiNkiqfRxbxeXCCYJaoqiS_DS04KX7P2tyGnV5fIWLW8Jvuto-gNnD0IO9_CoJpX5j0Qg2BLFswiiNGclwonozlWSMUMFUaoAGjHr1z7Auauj8Zl3hgykueOx3nL47zlcQBf-zWLtnzHvbO37oihXxK7rD1GRQAbnVxyv9frvNfMAEg_ipvUsV5VZn5V5wljDVJOAnjXSvOWtHtTQpj44V7Sn-DJaDo-zo8PJ0cb8LQLYYjoJgxQZuYjIqNVseX1kcD5Q2-BGz29H1U |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVICPEsoVB8gBOyNn7FmwNCVberltJtD620t-A4tnqosstmC_Sn8e8Yx0lQD_TWs-1RMjO2v_G8AD7w3HPmnaFKW0slIlhqsrykBpWpEspo5oOheDLLDi_k17mab8CfPhcmhFX2Z2J7UFcLG97IRyFaNg1pmCPfRUWcTaZflj9oaCAVHK19N42oIcfu5hdab83nowmK-iPn04Pz_UPaNRigVqh8TbOyRARh0rHjiJoc45Z7O07H3uYp_pnGDzaCW81KlhmWe2vzsTF4SSovlJBSIN0H8FALxcIW0_PB1gv-qVgIQQsqZT7v83UyOVpZ26bA5yEuQqXZ6f6tO_Hx0jQoHh_7avwf-LYX4PQpPOmQK9mLqvYMNlz9HLZOOt_8C5gd_F6vTHAEhMhWsleFMuQ4Qs7xXLpcNMtLhLXE1BXpCvKS07KrXvvTkbPrK2SrWd2QSXQZvYSLe2HmK9isF7V7DcQh7MpK4RHOWCkrg5PRMCszIxxTTpkEWM-vwnalzENHjauiNWkyWQQeF5HHReRxAp-GNctYyOPO2bu3xDAs4SF_TzCVwE4vl6Lb9U0x6GgCZBjF7RpYb2q3uG4KLUSLmXUC21Ga_0iH1yUEjG_uJP0etlDxi29Hs-MdeNTHMqTsLWyiyNw7hEjrcrdVRgLf71v7_wKU7CIl |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extracellular+Adenosine+Triphosphate+and+Chronic+Obstructive+Pulmonary+Disease&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Lommatzsch%2C+Marek&rft.au=Cicko%2C+Sanja&rft.au=M%C3%BCller%2C+Tobias&rft.au=Lucattelli%2C+Monica&rft.date=2010-05-01&rft.pub=American+Thoracic+Society&rft.issn=1073-449X&rft.eissn=1535-4970&rft.volume=181&rft.issue=9&rft.spage=928&rft_id=info:doi/10.1164%2Frccm.200910-1506OC&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2027524921 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon |